Clinical Trial

Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to determine whether Ropivacaine-Poloxamer 407 hydrogel provides non-inferior pain control compared to TAP block for patients undergoing minimally invasive gastrectomy. The results will guide postoperative pain management practices and enhance recovery protocols for gastric cancer surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-17.
Trial Details
NCT Number NCT06839716
Lead Sponsor Gangnam Severance Hospital
Conditions Gastric Cancer
Enrollment 134 participants
Start Date 2025-02-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-25